| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 515,144 | 528,986 | 521,265 | 530,141 | | Cost of Revenue | 208,521 | 206,961 | 211,341 | 209,807 | | | Gross Profit | 306,623 | 322,025 | 309,924 | 320,334 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 12,397 | 10,911 | 9,849 | 11,710 | | Non Recurring |
-
| 119,303 | 2,097 | 584 | | Others | 150,045 | 153,227 | 147,330 | 144,007 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 144,181 | 38,584 | 150,648 | 164,033 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,729 | 22,521 | 5,814 | 4,813 | | Earnings Before Interest And Taxes | 149,910 | 61,105 | 153,486 | 168,846 | | Interest Expense | 126,862 | 127,016 | 122,715 | 119,663 | | Income Before Tax | 23,048 | (65,911) | 30,771 | 49,183 | | Income Tax Expense | 2,131 | (655) | 1,317 | 1,726 | | Minority Interest |
-
| 3,256 | (1,823) | (4,043) | | | | Net Income From Continuing Ops | 23,487 | (59,291) | 30,857 | 43,319 | | | Non-recurring Events | | Discontinued Operations | 61,934 | 28,048 | 147,384 | 89,293 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 85,421 | (31,243) | 178,241 | 132,612 | | Preferred Stock And Other Adjustments | (8,246) | (3,620) | (3,628) | (3,626) | | | Net Income Applicable To Common Shares | $77,175 | ($34,863) | $174,613 | $128,986 |
|
0.45% Nasdaq 
0.20%
Income Statement
